1 – 10 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII
- The role of the laboratory in diagnosis and management of inhibitory antibodies in haemophilia
- Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis : Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network
- Replacement therapy during surgery in von Willebrand disease needs personalization
- Defining extended half-life rFVIII-A critical review of the evidence
- Fifth Åland Island conference on von Willebrand disease
- Immune tolerance induction : What have we learned over time?
- Evaluation of prophylactic therapy in haemophilia with global coagulation tests
- 2017
- Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
- Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits : A two-centre study